183 related articles for article (PubMed ID: 18493824)
1. A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.
Stewart JH; Shen P; Russell G; Fenstermaker J; McWilliams L; Coldrun FM; Levine KE; Jones BT; Levine EA
Ann Surg Oncol; 2008 Aug; 15(8):2137-45. PubMed ID: 18493824
[TBL] [Abstract][Full Text] [Related]
2. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.
Votanopoulos K; Ihemelandu C; Shen P; Stewart J; Russell G; Levine EA
J Surg Res; 2013 Jan; 179(1):e133-9. PubMed ID: 22480844
[TBL] [Abstract][Full Text] [Related]
3. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.
Stewart JH; Shen P; Russell GB; Bradley RF; Hundley JC; Loggie BL; Geisinger KR; Levine EA
Ann Surg Oncol; 2006 May; 13(5):624-34. PubMed ID: 16538401
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.
Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS
Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer.
Shen P; Thomas CR; Fenstermaker J; Aklilu M; McCoy TP; Levine EA
J Gastrointest Cancer; 2014 Sep; 45(3):268-75. PubMed ID: 24452995
[TBL] [Abstract][Full Text] [Related]
6. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
van Eden WJ; Kok NFM; Woensdregt K; Huitema ADR; Boot H; Aalbers AGJ
Eur J Surg Oncol; 2018 Feb; 44(2):220-227. PubMed ID: 29258720
[TBL] [Abstract][Full Text] [Related]
7. Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
van der Kaaij RT; Wassenaar ECE; Koemans WJ; Sikorska K; Grootscholten C; Los M; Huitema A; Schellens JHM; Veenhof AAFA; Hartemink KJ; Aalbers AGJ; van Ramshorst B; Boerma D; Boot H; van Sandick JW
Br J Surg; 2020 Oct; 107(11):1520-1528. PubMed ID: 32277764
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia.
Chalret du Rieu Q; White-Koning M; Picaud L; Lochon I; Marsili S; Gladieff L; Chatelut E; Ferron G
Cancer Chemother Pharmacol; 2014 Sep; 74(3):571-82. PubMed ID: 25053386
[TBL] [Abstract][Full Text] [Related]
9. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution.
Elias D; Bonnay M; Puizillou JM; Antoun S; Demirdjian S; El OA; Pignon JP; Drouard-Troalen L; Ouellet JF; Ducreux M
Ann Oncol; 2002 Feb; 13(2):267-72. PubMed ID: 11886004
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer.
Zeh HJ; Brown CK; Holtzman MP; Egorin MJ; Holleran JL; Potter DM; Bartlett DL
Ann Surg Oncol; 2009 Feb; 16(2):385-94. PubMed ID: 19034580
[TBL] [Abstract][Full Text] [Related]
11. A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.
Dumont F; Passot C; Raoul JL; Kepenekian V; Lelièvre B; Boisdron-Celle M; Hiret S; Senellart H; Pein F; Blanc-Lapierre A; Raimbourg J; Thibaudeau E; Glehen O;
Eur J Cancer; 2020 Nov; 140():37-44. PubMed ID: 33039812
[TBL] [Abstract][Full Text] [Related]
12. Effect of perfusion temperature on glucose and electrolyte transport during hyperthermic intraperitoneal chemoperfusion (HIPEC) with oxaliplatin.
Ceelen W; De Somer F; Van Nieuwenhove Y; Vande Putte D; Pattyn P
Eur J Surg Oncol; 2013 Jul; 39(7):754-9. PubMed ID: 22878060
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary experience with hyperthermic intraperitoneal chemo-perfusion with oxaliplatin for the treatment of peritoneal carcinomatosis due to colorectal carcinoma].
Mura G; Framarini M; Vagliasindi A; Cavaliere D; Tauceri F; Solfrini G; Milandria C; Verdecchia GM
Chir Ital; 2007; 59(2):217-23. PubMed ID: 17500178
[TBL] [Abstract][Full Text] [Related]
14. Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin.
Moaven O; Votanopoulos KI; Shen P; Mansfield P; Bartlett DL; Russell G; McQuellon R; Stewart JH; Levine EA
Ann Surg Oncol; 2020 Mar; 27(3):772-780. PubMed ID: 31720933
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.
Ceelen WP; Peeters M; Houtmeyers P; Breusegem C; De Somer F; Pattyn P
Ann Surg Oncol; 2008 Feb; 15(2):535-41. PubMed ID: 17960463
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
Lentz SS; Miller BE; Kucera GL; Levine EA
Gynecol Oncol; 2007 Jul; 106(1):207-10. PubMed ID: 17498782
[TBL] [Abstract][Full Text] [Related]
18. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion.
Ahmad SA; Kim J; Sussman JJ; Soldano DA; Pennington LJ; James LE; Lowy AM
Ann Surg Oncol; 2004 Apr; 11(4):387-92. PubMed ID: 15070598
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
Lam JY; McConnell YJ; Rivard JD; Temple WJ; Mack LA
Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744
[TBL] [Abstract][Full Text] [Related]
20. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
